PZI

Prescription Use Blood Glucose Meter For Near-Patient Testing

Product code
PZI
Device name
Prescription Use Blood Glucose Meter For Near-Patient Testing
Device class
Class 2
21 CFR
21 CFR 862.1345
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
510(k) clearances (last 3 years)
4
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
14 (all years; only the last 3 years are listed here)

FDA classification definition

Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (4)

Last three years. Most recent: 2026-06-12.

NumberDecision dateApplicantDevice nameSummary
K2523232026-06-12Roche Diagnosticscobas pulse blood glucose monitoring systemPDF
K2213492024-11-19Taidoc Technology CorporationXPER Technology PREMIUM Pro Blood Glucose Monitoring…PDF
K2202722024-04-26Roche Diagnosticscobas pulse blood glucose monitoring systemFDA
K2320752024-02-23Nova Biomedical CorporationStatStrip Glucose Hospital Meter SystemPDF

3 summaries are archived here for direct download.

Official FDA classification page: PZI
Classification and pathway per current FDA publications. Data from openFDA (CC0).